PreludeDx
Adam Hsiung has a robust background in laboratory sciences, currently serving as a Histotechnologist at PreludeDx since March 2023. Prior to this, Adam held various positions at NeoGenomics Laboratories from January 2017, progressing through roles such as Scientist I, II, and III, as well as Histotechnologist and Histotechnician in both Pharma Services and Anatomic Pathology. Adam earned a Bachelor of Science degree in Biochemistry and Cell Biology from UC San Diego between 2012 and 2016.
PreludeDx
PreludeDx delivers actionable tools to manage early stage breast cancer with the DCIS test that enables personalized treatment.